Nanotech Investing Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
Nanotech Investing Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer
nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
nanotech investing Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
nanotech investing ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox
nanotech investing Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
Harvest Gold Provides Update on its Ongoing Drill Program at Mosseau and Has Completed its High-Resolution Airborne Magnetic Survey of Mosseau and Labelle
